eli lilly gip/glp-1 What's Coming Next for GLP-1 and Metabolic Disease Treatment New clinical trial data from

Commonly prescribed GLP-1 receptor agonists in the UK include semaglutide (Ozempic for diabetes

Dietitians may use the results of this study as preliminary MNT guidance for this population

They were surprised that their food noise has decreased or disappeared

Tirzepatide prevents neurodegeneration through multiple molecular pathways

The strongest results people report also tend to cluster in the first one to two weeks, which is exactly when motivation, water intake, and effort are highest

I see people arguing that because we have not seen a clear increase in aspiration events, there is no need to treat these patients differently